“Our purpose is to give a voice to people who cannot verbalise their pain.”

PainChek Ltd

PainChek’s vision is to be first to market with innovative pain assessment products and services that improve quality of life for people in pain.

PainChek® is the world’s first pain assessment tool that has regulatory clearance in Australia and Europe.

Using AI and facial recognition technology, PainChek® provides carers across multiple clinical areas with three important new clinical benefits:

  1. The ability to identify the presence of pain, when pain isn’t obvious
  2. To quantify the severity level of pain, when pain is obvious, and;
  3. To monitor the impact of treatment to optimise overall care

PainChek® Apps are revolutionary.


Use of PainChek® Apps has international patent clearance. | Smart phone enabled medical Apps are rapidly growing within the Healthcare market.


Clear regulatory approval pathways. | Short time frame to commercialisation.

In Australia, there are 400,000 people living with dementia of which 115,000 are within residential aged care. At a global level, there are 50 million people living with dementia.

Pain is common

  • Up to 80% of people in aged care experience chronic pain


But pain often goes undetected and untreated

  • Pain is difficult to assess
  • Tools to assess pain are often not used or use subjective rating scales


Accurately identifying pain can

  • Improve quality of life
  • Reduce rates and severity of behavioural and psychological symptoms of dementia
  • Reduce rates of incorrectly prescribed antipsychotics
  • Improve staff retention
PainChek Ltd
PainChek Ltd
Philip Daffas celebrating the Tech Rocketship Award with Dave McCredie, Chief Executive Officer Australian British Chamber of Commerce and some of the other category winners.

PainChek wins UK tech Rocketship award “Tech for an Ageing Society”. Interest in the UK as a place for Aussie and Kiwi tech companies to grow is at an all-time high with 200 vying for the inaugural UK Tech Rocketship Awards.

“The Rocketship Award is a significant recognition of the PainChek® technology, the successful market introduction in Australia and the large overseas market potential. The award will provide PainChek® with financial support as well as the key contacts and processes to fast track our UK and European commercialisation in early 2019.”

Philip Daffas CEO PainChek Ltd

Our Team

Strong track record in clinical practice, R&D, innovation and commercialisation

Philip is a highly accomplished global business leader and people manager with an international career spanning more than 25 years with leading blue-chip healthcare corporates..


Philip Daffas
CEO & Managing Director, MBA, BSc

Jeff is a professor in the School of Pharmacy, Curtin University in Western Australia. Jeff served as the Head of the School of Pharmacy of Curtin University, from March 2009 to May 2014.


Prof. Jeff Hughes
Chief Scientific Officer PhD, MPS

Kreshnik is a registered community and consultant pharmacist with a PhD in Pharmacy and an accreditation from the Australian Association of Consultant Pharmacy.


Dr Kreshnik Hoti
Senior Research Scientist PhD, MPS

Andrew is a Psychologist, management consultant, business leader and executive coach. As a registered Psychologist, Andrew has worked in both Australia and the U.K..


Andy Hoggan
Manager – National Rollout

Ian is a chartered accountant and chartered secretary who acts as non-executive director and company secretary to ASX listed companies, trustee corporations, charitable trusts and private organisations.


Ian Hobson
Company Secretary

Scott has over 25 years’ experience designing, deploying and managing enterprise software systems.


Scott Robertson
Chief Technology Officer, MBA, B.Eng.(Comp. Systems)

David joins us with 15 years’ experience in the account management, relationship management and business development space.


David Allsopp
Head of Business Development ANZ

Dawn joins us with 16 years’ nursing experience. She completed her nurse training at West of Scotland University in Glasgow.


Dawn Kerr
Senior Clinical Specialist

Pete is a UK Healthcare Market leader with over 15 years of senior management experience across Health and Social Care.


Pete Shergill
Business Development Director, PainChek UK

Harj has worked in the healthcare industry for over 29 years, driving and implementing strategy. Has held various senior Operational roles managing large teams to drive sales & deliver excellence..


Harj Sadhra
Business Development Manager PainChek UK

Our Board

John has over 20 years’ experience in private equity and venture capital, and was a co- founder and Managing Partner of Technology Venture Partners; one of the original and leading venture capital firms in Australia.


John Murray
Non-Executive Director and Non-Executive Chairman of the Board

Philip is a highly accomplished global business leader and people manager with an international career spanning more than 25 years with leading blue-chip healthcare corporates..


Philip Daffas
CEO & Managing Director, MBA, BSc

Ross’ experience in the commercialisation of medical products spans over thirty years and over three continents.


Ross Harricks
Non-Executive Director, BSc, BEng(Hons), MBA (Distinction)

Adam is the Director, Private Clients and Institutional at Patersons Securities.


Adam Davey
Non-Executive Director